Evidence map›Paper›PMID 31490103›Full record

ArticleInternational journal of radiation biology2021

Medical countermeasures for radiation induced health effects: report of an Interagency Panel Session held at the NASA Human Research Program Investigator's Workshop, 26 January 2017.

Lisa S Carnell, Mary Homer, Keith Hoots, Heather Meeks, Pataje G S Prasanna, Carmen Rios, Lisa C Simonsen, Lanyn P Taliaferro, Lynne K Wathen

Abstract read
In one paragraph

Article in International journal of radiation biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa S CarnellNASA Langley Research Center, Hampton, VA, USA.
Mary HomerUS Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC, USA.
Keith HootsNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Heather MeeksDefense Threat Reduction Agency, Fort Belvoir, VA, USA.
Pataje G S PrasannaUS Department of Health and Human Services, Division of Cancer Treatment and Diagnosis, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Carmen RiosDivision of Allergy, Immunology and Transplantation (DAIT), Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA.
Lisa C SimonsenNASA Langley Research Center, Hampton, VA, USA.
Lanyn P TaliaferroDivision of Allergy, Immunology and Transplantation (DAIT), Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA.
Lynne K WathenUS Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC, USA.

Funding

Intramural NIH HHS Z99 AI999999
6 · The paper itself

Abstract

An Interagency Panel Session organized by the NASA Human Research Program (HRP) Space Radiation Program Element (SRPE) was held during the NASA HRP Investigator's Workshop (IWS) in Galveston, Texas on 26 January 2017 to identify complementary research areas that will advance the testing and development of medical countermeasures (MCMs) in support of radioprotection and radiation mitigation on the ground and in space. There were several areas of common interest identified among the various participating agencies. This report provides a summary of the topics discussed by each agency along with potential areas of intersection for mutual collaboration opportunities. Common goals included repurposing of pharmaceuticals, nutraceuticals for use as radioprotectors and/or mitigators, low-dose/chronic exposure paradigms, late effects post-radiation exposure, mixed-field exposures of gamma-neutron, performance decrements, and methods to determine individual exposure levels.

Indexed as

Medical CountermeasuresRadiation InjuriesRadiation ProtectionSpace FlightHumansNeutronsUnited StatesUnited States National Aeronautics and Space Administrationmedical countermeasuresmitigatorradiationradioprotectionSpace

Identifiers

PMID31490103
PMCPMC8463010

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.